Phospholipid composition and levels are altered in Down syndrome brain (Q33904262)

29 July 2017

Phospholipid composition and levels are altered in Down syndrome brain (English)

1 reference

29 July 2017

1 reference

3

Rapoport SI

1 reference

29 July 2017

2

Schapiro MB

1 reference

29 July 2017

Murphy EJ

1

1 reference

PubMed ID

10837793

29 July 2017

Shetty HU

series ordinal

4

1 reference

PubMed ID

10837793

29 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

29 July 2017

1 reference

29 July 2017

867

1 reference

29 July 2017

9-18

1 reference

29 July 2017

1-2

1 reference

Relation of age and apolipoprotein E to cognitive function in Down syndrome adults.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Phosphatidylinositol synthase from mammalian tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Oown's syndrome fetal brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Altered composition of polyunsaturated fatty acyl groups in phosphoglycerides of Down's syndrome fetal brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Gangliosides in the brain in adult Down's syndrome and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Cognitive impairment in adults with Down's syndrome: similarities to early cognitive changes in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Biochemical changes of rat brain membranes with aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

The role of altered sodium currents in action potential abnormalities of cultured dorsal root ganglion neurons from trisomy 21 (down syndrome) human fetuses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

The neurobiologic consequences of Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Membrane lipid changes in laminectomized and traumatized cat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Separation of phospholipids by high-performance liquid chromatography: all major classes, including ethanolamine and choline plasmalogens, and most minor classes, including lysophosphatidylethanolamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Ubiquinone, dolichol, and cholesterol metabolism in aging and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Oxidation of 1-O-(alk-1-enyl)-2,3-di-O-acylglycerols: Models for plasmalogen oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Membrane bilayer instability as a pathogenetic mechanism for neurological disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Regional specificity of membrane instability in Alzheimer's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Membrane instability, plasmalogen content, and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in down's syndrome and Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

CDP-diacylglycerol synthase from mammalian tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Nano-scale densitometric quantitation of phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Fatty Acid Composition of Lipids in Cerebral Myelin and Synaptosomes in Phenylketonuria and Down Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Alterations in erythrocyte membrane fluidity in children with trisomy 21: a fluorescence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Phosphatidylserine synthase I and II of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Brain vasopressin levels in Down syndrome and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Interleukin-1beta stimulates phospholipase A2 activity in adult rat ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Selective hydrolysis of plasmalogen phospholipids by Ca2+-independent PLA2 in hypoxic ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Separation of neutral lipids by high-performance liquid chromatography: quantification by ultraviolet, light scattering and fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Acidic hydrolysis of plasmalogens followed by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Electrical properties of cultured dorsal root ganglion neurons from normal and trisomy 21 human fetal tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Evidence for a membrane defect in Alzheimer disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Lumbar cerebrospinal fluid choline in healthy aging and in Down's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Alzheimer's disease and Down syndrome: leukocyte membrane fluidity alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

The versatility of inositol phosphates as cellular signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Polyol profiles in Down syndrome. myo-Inositol, specifically, is elevated in the cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Phospholipid composition of Down's syndrome and normal platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Membrane lipids in the aging human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Dendrites, dementia and the Down syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Ether lipid synthesis and its deficiency in peroxisomal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902205-8

10.1016/S0006-8993(00)02205-8

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10837793